Davos Agenda

Are vaccines enough? To end COVID-19 we need more innovation – and more access

A lab technician wearing a full-face mask and a protective suit holds tablets of investigational coronavirus disease (COVID-19) treatment drug "Favipiravir" at Eva Pharma Facility in Cairo, Egypt June 25, 2020. Picture taken June 25, 2020. REUTERS/Amr Abdallah Dalsh - RC2XGH94FFJG

New solutions to old problems ... patent pooling aims for fairer access to medical breakthroughs. Image: REUTERS/Amr Abdallah Dalsh

Elissa Prichep
Project Lead Precision Medicine, World Economic Forum
Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Davos Agenda

Have you read?

What is the World Economic Forum doing about fighting pandemics?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Davos AgendaCOVID-19VaccinationGlobal HealthHealth and Healthcare
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Davos and beyond: A timeline of the highlights

Gayle Markovitz and Ceri Parker

December 8, 2023

About Us



Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum